DrugDashboards

Cnj-016

Vaccinia Immune Globulin Intravenous (Human) · HUMAN VACCINIA VIRUS IMMUNE GLOBULIN 1 [iU]/mL · Injection · Intravenous · Emergent BioSolutions Canada Inc.

NDC 60492-0173-02 · 24 VIAL, SINGLE-USE in 1 CARTON / 12 mL in 1 VIAL, SINGLE-USE · BLA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 2 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
BLA125109
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Vaccinia Immune Globulin Intravenous (Human) (Injection)

LabelerStrengthFirst seenLast seen
Emergent BioSolutions Canada Inc.HUMAN VACCINIA VIRUS IMMUNE GLOBULIN 1 [iU]/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Cnj-016 — NDC 60492-0173-02," retrieved September 3, 2026, https://drugdashboards.com/drug/60492017302.

Free to cite with attribution — see how the data is put together.